De Dora Capital, Inc. Astrazeneca PLC Transaction History
De Dora Capital, Inc.
- $404 Million
- Q3 2025
A detailed history of De Dora Capital, Inc. transactions in Astrazeneca PLC stock. As of the latest transaction made, De Dora Capital, Inc. holds 4,302 shares of AZN stock, worth $384,598. This represents 0.08% of its overall portfolio holdings.
Number of Shares
4,302
Previous 4,302
-0.0%
Holding current value
$384,598
Previous $300,000
10.0%
% of portfolio
0.08%
Previous 0.08%
Shares
4 transactions
Others Institutions Holding AZN
# of Institutions
1,501Shares Held
500MCall Options Held
5.59MPut Options Held
3.18M-
Price T Rowe Associates Inc Baltimore, MD49.1MShares$4.39 Billion0.4% of portfolio
-
Primecap Management CO Pasadena, CA39.9MShares$3.56 Billion2.42% of portfolio
-
Bank Of America Corp Charlotte, NC32.6MShares$2.92 Billion0.18% of portfolio
-
Wellington Management Group LLP Boston, MA32.3MShares$2.89 Billion0.45% of portfolio
-
Capital International Investors Los Angeles, CA25.1MShares$2.24 Billion0.33% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $277B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...